Of course but the question is where will we start when
Of course but the question is where will we start when moving forward with HIV. Will the long-acting virtual cure with big money potential be early-stage? What will it take to get that towards the finish line? We could refile the MDR BLA and generate revenue from that, which would be fantastic, but that won't be in the billions of dollars.
NASH and cancer need pivotal trials and it's still not clear that the next phase for each will be pivotal. One or both could be but that hasn't been specified yet as far as I know. We're like tons of other speculative investments in that we have a good amount of uncertainty and seeing through that uncertainty is where big money is made if you get it right, but the unknown always equals risk as well that needs to be priced in by the market. I'm just trying to look at how the market sees us.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Introducing Mopar's Evolution at SEMA 2024 AUBURN HILLS, Mich. – The pinnacle of the automotive world is gathering at SEMA 2024, and Mopar is set to unveil revolutionary advancements that will redefine the muscle car experience. With the muscle car legacy rooted deeply in performance, the upcoming event raises the question of just how high the boundaries can be pushed...
Continue Reading
Allied Properties REIT Announces September 2024 Distribution Allied Properties REIT (“Allied”) (TSX:AP.UN) has declared that its Trustees have approved a distribution of $0.15 per unit for September 2024. This results in an annualized rate of $1.80 per unit. The distribution will be payable on a designated date to all unitholders who are on record by the end of the...
Continue Reading
Resecurity to Showcase AI-Driven Cybersecurity at the Global AI Summit 2024 Resecurity, a leader in cybersecurity, will take part in the Global AI Summit (GAIN) 2024. The event brings together experts and innovators to examine how advances in artificial intelligence are reshaping real-world applications across industries—security included. Spotlight on AI-Powered Cyber...
Continue Reading
Understanding the Opportunity for Action Investors holding shares of Savara Inc. (NASDAQ: SVRA) may find an important opportunity to engage in a class action lawsuit. The law firm spearheading this effort, known for its focus on shareholder rights, is reaching out to those affected by possible misstatements made by the company. What Led to the Class Action Lawsuit? The...
Continue Reading
Arteris Celebrates Triumph at the International Business Awards Arteris, Inc. (Nasdaq: AIP), a prominent name in the semiconductor industry, is making waves after winning a Gold Stevie Award for being the Most Innovative Tech Company of the Year. This accolade comes from the highly competitive 22nd Annual International Business Awards, where companies across the globe vie...
Continue Reading
